Navigation Links
Consumer and manufacturing groups back bill to protect US drug supply
Date:8/3/2010

The Pew Prescription Project, joined by major consumer, physician and chemical manufacturer groups, today announced support for a new bill that would give the U.S. Food and Drug Administration (FDA) much-needed authorities to better protect pharmaceutical supply chains. The organizations made the announcement in a joint letter to Congress and during an audio news conference with Senator Michael Bennet (D-CO), who will introduce this drug safety legislation.

Consumers face a surge in drug recalls, with a 400 percent increase in 2009 compared with the previous year. This year, the trend has continued with the high-profile voluntary recall of over 130 million bottles of over-the-counter children's drugs.

To boost consumer protections against adulterated drugs, the proposed legislation would establish quality standards for the FDA, drug companies and their contractors, who are increasingly based overseas, where safeguards may be lower than in the U.S. The legislation also would improve the federal government's tracking systems of manufacturing sites. The FDA has recently signaled it will strengthen inspection and quality requirements for drug makers who outsource to suppliers and suggested the agency should have the authority, currently lacking, to require a company to recall drugs that have been found to be contaminated or unsafe.

In the wake of more than 100 U.S. deaths associated with contaminated heparin from China, Americans' trust in imported drugs has been badly shaken. A survey commissioned this spring by the Pew Prescription Project found an overwhelming majority of Americans94 percentsupport giving the FDA authority to recall drugs when they are found unsafe or contaminated. This poll of likely voters found that 70 percent of respondents have little or no confidence that drugs manufactured in China are free from contamination and safe for Americans and 54 percent expressed the same concern about drugs manufactured in India. The bipartisan polling was conducted by Hart Research Associates and Public Opinion Strategies.

"According to our polling, most Americans lack confidence that drugs made in India and China today are safe," said Allan Coukell, director of the Pew Prescription Project. "The Drug Safety and Accountability Act takes needed steps toward rebuilding that trust by giving the FDA new authorities to recall drugs and establishing some important safeguards to ensure the quality and safety of drugs and drug ingredients."

"This bill is a critical step toward improving the safety of the prescription drugs millions of Americans depend on every day," said David Sloane, AARP senior vice president. "It gives the FDA the necessary authority to ensure strong quality standards protecting U.S. consumers are upheld in the U.S. and around the world, and encourages the rapid sharing of information to help quickly identify and act on quality control issues."

"Physicians support strong efforts to ensure that the drugs they prescribe to their patients are safe and effective," said J. Fred Ralston, Jr., MD, FACP, president of the American College of Physicians. "This legislation is an important step toward safeguarding the nation's drug supply by improving quality standards and strengthening the FDA's ability to track the domestic and foreign drug supply."

Brant Zell, chairman of the Society of Chemical Manufacturers of America (SOCMA) Bulk Pharmaceutical Task Force, said, "Our members strongly endorse legislation that strengthens the FDA and increases public safety and health with a more secure drug supply. We believe this legislation is a good starting point. Today, about 80 percent of the drugs' active ingredients come from overseas in countries like India and China. However, imported drugs receive less than 5 percent of FDA's resources. Senator Bennet's bill will give the FDA more authority, tools and resources to help ensure a safe U.S. drug supply."

"This bill gives us important new protections against contamination of the drugs Americans depend on every day," said Marcia Hams, director of Prescription Access and Quality at Community Catalyst, a national consumer health organization. "With more drug manufacturing outsourced to other countries with weak oversight, the FDA must be able to set strong standards and enforce them through recalls of defective drugs and penalties."

"We hope that this legislation can be approved in the remaining days of this Congressbefore consumers are again faced with another Chinese-heparin-type case of death and injury from unsafe, contaminated and corrupted drugs," said William Vaughan, health policy analyst at Consumers Union.


'/>"/>

Contact: Linda Paris
lparis@pewtrusts.org
202-540-6354
Pew Health Group
Source:Eurekalert

Related medicine news :

1. Suite 101.com Provides Insight Into Consumer Reading Behavior Online
2. AchooAllergy.com Adds Allergist Interviews to Monthly Allergy Consumer Report Newsletter
3. Aesthetic Society Launches Project Beauty, NEW Consumer Website Covering All Things Beauty
4. Surf Sweets Among Few Candy Offerings Free of Synthetic Dyes Despite Growing Consumer Concern Over Affect on Children
5. Online Broker Lets Consumers Choose The Price of Life Insurance
6. The Time is Now to Capitalize on Today's Direct-to-Consumer Health Insurance Opportunity via the Exchange Marketplace
7. Better Hearing Institute Publishes Comprehensive Consumer Guide to Buying Hearing Aids
8. Older Chinese consumers perceive themselves younger than actual age
9. IADR and GSK Consumer Healthcare announce winners of 2010 Innovation in Oral Care Awards
10. Skincancer.com Launches With Latest News, Information and Help for Consumers/Patients and Physicians
11. Are Fish Oil Supplements a Waste of Money? Healthy-Oil-Planet.com Helps Consumers Make Informed Decisions on Nutritional Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ ... Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes the tragedies he ... and his attempts to overcome them. , Schanssema, initially unsure of the career path ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The International ... 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected ... will be showcased and the winner revealed at the 31st annual iaedp Symposium, March ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to ... Elite division on February 12th. Ms. Esparza qualified into this prestigious status ... competition held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... The 89th ... the winner of the 2016 National Education Policy Center Bunkum Award. We invite you ... in 2016. , This year’s Bunkum winner is the Center for American Progress (CAP), ...
(Date:2/23/2017)... Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... first two episodes of WE TV’s “Mama June: From Not to Hot,” which will ... TV notable, “Mama” June Shannon, known to millions from the 2012 reality television series, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... LG Innotek hat heute die weltweit erste ... das 1,5-fache des 45-mW-Moduls der Konkurrenz. UV-C ... und 280 nm und eignet sich damit für Sterilisationsaufgaben. Es ... zerstört. Das Produkt von LG Innotek erzeugt UV-Strahlung im ... ...
(Date:2/23/2017)... -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare ... ended 31 December 2016 compared with the previous corresponding period. A ... here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: 1.2 ... $15.7m; up 11%) Profit before tax of $2.12m ...
(Date:2/23/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - 2016, provides ... research answers the following questions: What are ... they positioned in the Global Menopause market? What are ...
Breaking Medicine Technology: